REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer

Transl Cancer Res. 2020 Feb;9(2):402-404. doi: 10.21037/tcr.2019.12.83.

Authors

Daniele Lavacchi¹, Sara Fancelli¹, Marta Rita Gatta Michelet¹, Martina Catalano¹, Giandomenico Roviello²

Affiliations

¹ School of Human Health Sciences, University of Florence, Florence, Italy.
² Department of Health Sciences, University of Florence, Florence, Italy.

No abstract available

Publication types

Editorial
Comment